LifeMD
Stock Forecast, Prediction & Price Target
LifeMD (LFMD) stock Price Target by analysts
$12
Potential upside: 97.35%
LifeMD price prediction
What is LifeMD stock analysts` prediction?
LifeMD stock forecast: Based on 1 Wall Street analysts` predicted price targets for LifeMD in the last 3 months, the avarage price target is $12, with a high forecast of $NaN. The average price target represents a 97.35% change from the last price of $6.08.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
LifeMD stock Price Target by analysts
Full breakdown of analysts given LifeMD price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Kyle Bauser BTIG | 0% 0/1 | 12 months ago | $12 97.35% upside | $4.64 | StreetInsider | Previous targets (0) |
Steve Dechert KeyBanc | 0% 0/1 | over 1 year ago | $12 97.35% upside | $7.53 | TheFly | Previous targets (0) |
David Larsen BTIG | 0% 0/1 | over 1 year ago | $14 130.25% upside | $10 | StreetInsider | Previous targets (0) |
LifeMD Financial Estimates
LifeMD Revenue Estimates
LifeMD EBITDA Estimates
LifeMD Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $92.87M N/A | $119.03M 28.16% | $152.54M 28.15% | Avg: $254.74M Low: $248.54M High: $258.87M avg. 66.99% | Avg: $295.3M Low: $289.65M High: $301.47M avg. 15.91% | ||
Net Income
% change YoY
| $-61.32M N/A | $-45.02M 26.58% | $-20.59M 54.25% | Avg: $3.83M Low: $-8.13M High: $26.78M avg. 118.62% | Avg: $-1.7M Low: $-12.18M High: $-11.57M avg. -144.31% | ||
EBITDA
% change YoY
| $-49.43M N/A | $-32.21M 34.83% | $-8.21M 74.50% | Avg: $-104.93M Low: $-106.62M High: $-102.37M avg. -1177.41% | Avg: $-121.63M Low: $-124.17M High: $-119.31M avg. -15.91% | ||
EPS
% change YoY
| -$2.27 N/A | -$1.45 36.12% | -$0.7 51.72% | Avg: $0.13 Low: -$0.24 High: $0.79 avg. 118.85% | Avg: -$0.35 Low: -$0.36 High: -$0.34 avg. -365.15% | ||
Operating Expenses
% change YoY
| $129.18M N/A | $140.05M 8.41% | $148.46M 6.00% | Avg: $321.20M Low: $313.38M High: $326.41M avg. 116.35% | Avg: $372.34M Low: $365.23M High: $380.12M avg. 15.91% | ||
FAQ
What is LifeMD stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -12.84% in 2025-2026.
We have gathered data from 3 analysts. Their low estimate is -8.13M, average is 3.83M and high is 26.78M.
What is LifeMD stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 41.45% in 2025-2026.
We have gathered data from 4 analysts. Their low revenue estimate is $248.54M, average is $254.74M and high is $258.87M.
What is LifeMD stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -123.14% in 2025-2026.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.24, average is $0.13 and high is $0.79.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering LifeMD stock. The most successful analyst is Kyle Bauser.